Our experiments suggest that phosphorylation, which appears to be critical in Parkinson’s disease, adds “aggregation” capacity to the α-Synuclein assemblies and as such may regulate the onset of neuronal dysfunction. The gene discussed is SNCA; the disease is Parkinson disease.